(RCUS) |
| 0 (0%) 08-01 20:05 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 31.74 |
| Resistance 1: | 29.42 |
| Pivot price: | 28.13 |
| Support 1: | 25.68 |
| Support 2: | 21.37 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -3.170 |
| Book Value | 4.180 |
| PEG Ratio | 0.00 |
| Gross Profit | -2.282 |
| Profit Margin (%) | -156.36 |
| Operating Margin (%) | -788.23 |
| Return on Assets (ttm) | -23.1 |
| Return on Equity (ttm) | -69.9 |
Company news
Sat, 01 Aug 2026
How Investors May Respond To Arcus Biosciences (RCUS) Expanding ARC-20 With New Kidney Cancer Combo - simplywall.st
Thu, 30 Jul 2026
Earnings Preview: RCUS to Report Financial Results Post-market on August 05 - Moomoo
Thu, 30 Jul 2026
Arcus Biosciences Inc (RCUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wed, 29 Jul 2026
RCUS|Arcus Biosciences Inc|Price:26.470|Chg%:-0.580 - TradingKey
Mon, 27 Jul 2026
Three new Arcus employees receive options and 6,300 restricted stock units - Stock Titan
Sat, 25 Jul 2026
Price to earnings forward of Arcus Biosciences, Inc. – NYSE:RCUS - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
